drugset / Trial / NCT01950312
The Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease
Phase 2
Completed
10 enrolled
XOMA (US) LLC
Feinstein Institute for Medical Research · collabNational Institute on Deafness and Other Communication Disorders (NIDCD) · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if gevokizumab therapy may be an alternate therapy in patients with steroid resistant Autoimmune Inner Ear Disease.
Timeline
- Start
- 2013-08
- Primary completion
- 2015-10
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gevokizumab | Monoclonal antibody | — | Subcutaneous |